Release Date: 02/06/15 10:55 Summary: Appointment to Capital Raise $100m for Fund Price Sensitive: Yes Download Document 178.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%